Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
PMID 17699297
The FDA has not approved ozone for any medical condition and does not recognize it as safe or effective for the treatment of any disease
In cancer, MDSCs adapt to the anoxic tumor microenvironment by upregulating mechanistic target of rapamycin (mTOR) and HIF-1 signaling, as well as expression of lipid uptake scavenger receptors (e.g., CD36 and macrophage scavenger receptor 1 [MSR1]) and key fatty acid oxidation enzymes (e.g., CPT1A, acyl-CoA dehydrogenase medium chain [ACADM], hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha [HADHA], and peroxisome proliferator-activated receptor coactivator 1 beta [PGC-1]) (6164)
Not for Pregnant Women $12-30 Min
PubMed laboratory research record [PMID: 40351930] PubMed record related to this compound for laboratory literature review
